GYY4137, a hydrogen sulfide (H2S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway
Authors:
- 14 February 2014
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 44 (4) , 1259-1267
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 37 references indexed in Scilit:
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated TumorigenesisCancer Cell, 2009
- Novel advancements in the management of hepatocellular carcinoma in 2008Journal of Hepatology, 2008
- JAK-STAT Signaling: From Interferons to CytokinesJournal of Biological Chemistry, 2007
- Genomics and Signaling Pathways in Hepatocellular CarcinomaSeminars in Liver Disease, 2007
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Identification of a Genetic Signature of Activated Signal Transducer and Activator of Transcription 3 in Human TumorsCancer Research, 2005
- Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cellsNature Medicine, 2003
- Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cellsOncogene, 2002
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cellsOncogene, 2001